Kamedis Dandruff Recall: Subpotent Zinc Pyrithione
Taro Pharmaceuticals recalls Kamedis Bio-Herbal Dandruff Care kits due to subpotent active ingredient levels. Check your lot numbers and expiration dates.
Use caution until it’s fixed
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Contact the company
What happened, in plain English
Taro Pharmaceuticals U.S.A., Inc. is recalling specific lots of the Kamedis Bio-Herbal Dandruff Care Therapeutic 2-Step System because the active ingredient, zinc pyrithione, was found to be subpotent (out of specification). This means the product may not work as intended for treating dandruff. The recall affects approximately 17,100 kits distributed nationwide. Read more at govinfonow.com/recall/42600-kamedis-dandruff-recall-subpotent-zinc-pyrithione.
Source Summary by GovInfoNow · govinfonow.com/recall/42600-kamedis-dandruff-recall-subpotent-zinc-pyrithione · Updated October 9, 2026 · FDA enforcement record: FDA #D-0134-2017
Cite this page
“Kamedis Dandruff Recall: Subpotent Zinc Pyrithione.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42600-kamedis-dandruff-recall-subpotent-zinc-pyrithione. Based on FDA recall #D-0134-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0134-2017%22&limit=1).
Why it’s dangerous
The hazard is that the assay values for the active ingredient, zinc pyrithione, were out of specification during stability testing. This results in a subpotent drug, meaning the concentration of the active ingredient may be lower than labeled, potentially rendering the treatment ineffective for its intended purpose.
Who’s affected
Consumers who purchased the Kamedis Bio-Herbal Dandruff Care Therapeutic 2-Step System (Step 1 and Step 2) from anywhere in the United States. Individuals relying on this product for effective dandruff treatment are most at risk of it not working properly.
How to tell if you have this one
Look for the product name 'Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM'. Check the NDC numbers: Step 1 is NDC 51672-2126-0 and Step 2 is NDC 51672-2125-5. Affected lots are E601, E602, E603, E604, E608, E609 (Expire September 2017) and E610, E611 (Expire October 2017).
- Brand
Kamedis- Category
Drug
What to do — step by step
Check Your Product Details
Verify if your kit matches the affected NDC numbers and lot numbers listed in the recall record.
Discontinue Use If Affected
If you have one of the recalled lots, stop using the product as it may not provide the expected therapeutic benefit.
Contact Manufacturer for Remedy
The recall record does not specify a remedy or return process; contact Taro Pharmaceuticals U.S.A., Inc. directly for further instructions.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0134-2017 (May 26, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0134-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.